Grand Pharmaceutical Group マネジメント
マネジメント 基準チェック /34
Grand Pharmaceutical Group's CEO is Chao Zhou, appointed in Jun 2021, has a tenure of 3.42 years. total yearly compensation is HK$1.87M, comprised of 90.8% salary and 9.2% bonuses, including company stock and options. directly owns 0.01% of the company’s shares, worth HK$1.62M. The average tenure of the management team and the board of directors is 3.4 years and 3.4 years respectively.
主要情報
Chao Zhou
最高経営責任者
HK$1.9m
報酬総額
CEO給与比率 | 90.8% |
CEO在任期間 | 3.4yrs |
CEOの所有権 | 0.01% |
経営陣の平均在職期間 | 3.4yrs |
取締役会の平均在任期間 | 3.4yrs |
経営陣の近況
Recent updates
CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | HK$2b |
Mar 31 2024 | n/a | n/a | HK$2b |
Dec 31 2023 | HK$2m | HK$2m | HK$2b |
報酬と市場: Chao's total compensation ($USD240.97K) is below average for companies of similar size in the Hong Kong market ($USD496.15K).
報酬と収益: Insufficient data to compare Chao's compensation with company performance.
CEO(最高経営責任者
Chao Zhou (34 yo)
3.4yrs
在職期間
HK$1,873,000
報酬
Mr. Chao Zhou serves as Chief Executive Officer of Grand Pharmaceutical Group Limited (formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited) since June 01, 2021 and serves as its Ex...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Executive Chairman | 3.4yrs | HK$2.89m | 0.021% HK$ 3.3m | |
CEO & Executive Director | 3.4yrs | HK$1.87m | 0.010% HK$ 1.6m | |
Executive Director | 1.4yrs | HK$25.00k | データなし | |
Investor Relations Director | no data | データなし | データなし | |
Executive Director | less than a year | データなし | 0.017% HK$ 2.6m | |
Company Secretary | 13.2yrs | データなし | データなし | |
Chairman of Grand Pharm (China) | no data | データなし | データなし | |
Vice President | no data | データなし | データなし |
3.4yrs
平均在職期間
51yo
平均年齢
経験豊富な経営陣: 512's management team is considered experienced (3.4 years average tenure).
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Executive Chairman | 3.4yrs | HK$2.89m | 0.021% HK$ 3.3m | |
CEO & Executive Director | 1.4yrs | HK$1.87m | 0.010% HK$ 1.6m | |
Executive Director | 1.4yrs | HK$25.00k | データなし | |
Executive Director | less than a year | データなし | 0.017% HK$ 2.6m | |
Chairman of Grand Pharm (China) | no data | データなし | データなし | |
Independent Non-Executive Director | 19.7yrs | HK$180.00k | データなし | |
Independent Non-Executive Director | 5.9yrs | HK$60.00k | データなし | |
Independent Non-Executive Director | 13.5yrs | HK$100.00k | データなし | |
Director of Grand Pharm (China) | 30.8yrs | データなし | データなし | |
Director of Zhejiang Xianju Xianle Pharmaceutical Company Limited | no data | データなし | データなし | |
Non-Executive Director | less than a year | データなし | データなし |
3.4yrs
平均在職期間
57yo
平均年齢
経験豊富なボード: 512's board of directors are considered experienced (3.4 years average tenure).